Janux Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-1.341; its P/E ratio is -38.66; Janux Therapeutics Inc is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 2.52M	$ 1.06M	-	$ 2.85M	$ 1.81M
Gross Profit	$ 2.52M	$ 1.06M	-	-	-
EBIT	$ -11.57M	$ -17.51M	$ -20.28M	$ -18.27M	$ -18.02M
EBITDA	-	$ -18.88M	$ -21.51M	$ -19.16M	$ -17.77M
Net Income Common Stockholders	$ -11.57M	$ -17.51M	$ -17.46M	$ -16.07M	$ -16.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 349.71M	$ 303.29M	$ 316.88M	$ 327.02M	$ 338.76M
Total Assets	$ 386.85M	$ 341.50M	$ 352.96M	$ 364.01M	$ 375.76M
Total Debt	$ 24.89M	$ 25.23M	$ 25.54M	$ 25.30M	$ 24.09M
Net Debt	$ -324.82M	$ -278.06M	$ -291.33M	$ -301.71M	$ -314.67M
Total Liabilities	$ 37.90M	$ 42.03M	$ 41.69M	$ 43.27M	$ 44.24M
Stockholders Equity	$ 348.95M	$ 299.51M	$ 311.26M	$ 320.74M	$ 331.51M
Cash Flow	-
Free Cash Flow	-	$ -15.63M	$ -14.20M	$ -13.97M	$ -15.93M
Operating Cash Flow	$ -11.71M	$ -15.05M	$ -13.91M	$ -11.91M	$ -13.41M
Investing Cash Flow	$ -61.45M	$ 17.87M	$ -8.74M	$ -1.60M	$ 19.76M
Financing Cash Flow	$ 56.61M	$ 528.00K	$ 1.58M	$ 191.00K	$ 0.00

Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

Income Statement >

Janux Therapeutics Inc Debt to Assets

Balance Sheet >

Janux Therapeutics Inc Cash Flow

Cash Flow >

Janux Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing